focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJudges Scientific Regulatory News (JDG)

Share Price Information for Judges Scientific (JDG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11,650.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 400.00 (3.448%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 11,650.00
JDG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Change

10 Sep 2020 07:00

RNS Number : 5444Y
Judges Scientific PLC
10 September 2020
 

Press Release

 

 

 

Judges Scientific plc

 

("Judges Scientific")

 

Board Change

 

Judges Scientific, the group focused on acquiring and developing companies in the scientific instrument sector, announces the appointment of Lushani Kodituwakku as an independent Non-Executive Director from 23 September 2020.

Lushani is the founder and CEO of Luminii Consulting, a consulting firm specialising in strategy, Commercial Due Diligence ("CDD") and value creation. She founded Luminii in 2017 after setting up and heading the Grant Thornton Strategy and CDD team in 2008 and holding various other senior roles with KPMG, Frost & Sullivan, PMSI and Neovian Partners.

Lushani has delivered several complex strategy & CDD projects since 1999 to large corporates, SMEs, private equity, venture capital and banks in the UK, Europe and USA looking to invest, enter new markets, diversify, redefine their business strategy and business models, making her one of the most experienced CDD and strategy advisors in the UK.

Lushani holds a Bachelor of Science (BSc) in Economics with first-class honours, and a Master of Research (MRes) in Management and Organisational Behaviour.

Lushani will also join the Remuneration committee, replacing Alex Hambro. The Board committees will comprise as follows:

Remuneration committee - Charles Holroyd (chair), Ralph Elman, Lushani Kodituwakku

Audit committee - Ralph Elman (chair), Charles Holroyd, Ralph Cohen

 

Commenting on the appointment, Alex Hambro, Chairman of Judges, said

"We are delighted to welcome Lushani to the Group. Lushani brings extensive expertise in strategy, CDD and value creation. We look forward to her guidance over the coming years as the Group continues to execute its buy and build growth strategy."

 

 

Judges Scientific

 

 

David Cicurel, CEO

Brad Ormsby, Group FD

  Tel: +44 (0) 20 3829 6970

 

Shore Capital (Nominated Adviser & Joint Broker)

 

 

Stephane Auton

Edward Mansfield

Sarah Mather

Tel: +44 (0) 20 7408 4090

 

 

Liberum (Joint Broker)

Bidhi Bhoma

Euan Brown

 

Alma (Financial Public Relations)

Rebecca Sanders-Hewett

Sam Modlin

 

 

Tel: +44 (0) 20 3100 2222

 

 

 

 

Tel: +44 (0) 20 3405 0205

 

 

Regulatory Information

The following disclosures in relation to the appointment of Lushani Dileeka Kodituwakku, aged 46, are required pursuant to Schedule 2(g) of the AIM Rules for Companies:

 

 Current directorships and partnerships:

Past directorships and partnerships held over the last five years:

Anukampa Bhikkhuni Project

 

Ceylon Tea Centre Limited

 

Luminii Consulting

 

 

Lushani Kodituwakku has confirmed that there is no other additional information to be disclosed under Schedule 2 (g) of the AIM Rules.  

 

 

Notes to editors: 

 

Judges Scientific plc (AIM: JDG), is a group focused on acquiring and developing companies in the scientific instrument sector. The Group consists of 18 businesses acquired since it was re-admitted to AIM in 2005.

 

The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, the scientific communities, manufacturers and regulatory authorities. The UK is a recognised centre of excellence for scientific instruments. The Group companies hold five Queen's Awards for innovation and export.

 

The Group's companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins.

 

Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash. Shareholder returns are created through the repayment of debt, organic growth and dividends.

 

For further information, please visit www.judges.uk.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFLFEAAIIAIII
Date   Source Headline
27th Jun 20137:00 amRNSAcquisition and Trading Update
7th Jun 20133:24 pmRNSDirector/PDMR Shareholding
29th May 20135:17 pmRNSResult of AGM
10th May 20134:06 pmRNSDirector/PDMR Shareholding
12th Apr 20133:30 pmRNSIssue of Equity
9th Apr 201311:59 amRNSDirector/PDMR Shareholding
22nd Mar 20137:00 amRNSFinal Results
8th Mar 201311:30 amRNSNotice of Results
7th Mar 20132:41 pmRNSDirector/PDMR Shareholding
8th Feb 20133:54 pmRNSDirector/PDMR Shareholding
24th Jan 20137:00 amRNSTrading Statement
17th Jan 201310:55 amRNSIssue of Equity
14th Jan 20132:43 pmRNSIssue of Equity
8th Jan 20133:24 pmRNSDirector/PDMR Shareholding
17th Dec 20122:11 pmRNSIssue of Equity
10th Dec 20123:28 pmRNSDirector/PDMR Shareholding and issue of equity
4th Dec 20123:06 pmRNSIssue of Equity
21st Nov 20127:00 amRNSTrading Statement
8th Nov 20125:22 pmRNSDirector/PDMR Shareholding
5th Nov 20122:24 pmRNSDirector/PDMR Shareholding
5th Nov 201210:14 amRNSDirector's Details
29th Oct 20122:22 pmRNSDirector/PDMR Shareholding
9th Oct 201212:05 pmRNSDirector/PDMR Shareholding
3rd Oct 20122:28 pmRNSHolding(s) in Company
25th Sep 20126:28 pmRNSHolding(s) in Company
25th Sep 20127:00 amRNSHalf Yearly Report
7th Sep 20123:19 pmRNSDirector/PDMR Shareholding
6th Sep 201211:31 amRNSNotice of Results
31st Aug 20129:52 amRNSHolding(s) in Company
24th Aug 20127:00 amRNSDirector/PDMR Shareholding
22nd Aug 20123:44 pmRNSHolding(s) in Company
21st Aug 20127:00 amRNSDirector/PDMR Shareholding
8th Aug 20123:13 pmRNSDirector/PDMR Shareholding
23rd Jul 20125:34 pmRNSDirector/PDMR Shareholding
18th Jul 20127:00 amRNSTrading Statement
9th Jul 20125:43 pmRNSDirector/PDMR Shareholding
29th Jun 201212:17 pmRNSDirector/PDMR Shareholding
29th Jun 20127:00 amRNSDirector/PDMR Shareholding
22nd Jun 20127:00 amRNSDirector/PDMR Shareholding
21st Jun 20125:17 pmRNSHolding(s) in Company
7th Jun 20124:36 pmRNSDirector/PDMR Shareholding
30th May 20125:16 pmRNSResult of AGM
22nd May 20126:18 pmRNSDirector/PDMR Shareholding
17th May 20123:31 pmRNSHolding(s) in Company
17th May 20123:16 pmRNSHolding(s) in Company
16th May 20125:14 pmRNSHolding(s) in Company
11th May 201212:07 pmRNSDirector/PDMR Shareholding
10th May 201210:00 amRNSIssue of Equity
9th May 201211:33 amRNSHolding(s) in Company
23rd Apr 20125:24 pmRNSExercise of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.